Platelet Rich Plasma (PRP) Therapy in Santa Ana, CA

CDC PLACES vs. JE: two files, not one brochure

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 13% of adults in Santa Ana have diagnosed diabetes — 1.0 points above the U.S. 12% figure. 20.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick platelet rich plasma therapy against that mix.

Where Santa Ana programs actually stall

• CDC PLACES (2023, crude) estimates 13% of adults in Santa Ana have diagnosed diabetes — 1.0 points above the U.S. 12% figure. Adult arthritis here is 15.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Separate 361 tissue, PRP, and CTP tickets before you market platelet rich plasma therapy in Santa Ana. Mixing lanes is how recoupments start.
• JE (Noridian Healthcare Solutions) is the contractor that will review CTP units, application frequency, and wound measurements for California Part B claims. Practices that skip MAC education typically see denials before they see outcomes.
• In a city of 250k–500k, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Santa Ana street address.

What CDC PLACES and JE each actually tell you

JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Santa Ana is 13% or not. PLACES is planning data. The LCD is the claim.

Before the first platelet rich plasma therapy shipment